Trifluoroacetic acid → HCID 11633860, compound
Reaction equation
C([O:5][C:6](=[O:36])[CH2:7][CH2:8][N:9]1[CH2:14][CH2:13][CH:12]([C:15]2[CH:20]=[CH:19][C:18]([CH2:21][O:22][C:23]3[CH:28]=[CH:27][C:26]([CH:29]4[CH2:34][CH2:33][S:32][CH2:31][CH2:30]4)=[C:25]([CH3:35])[CH:24]=3)=[CH:17][CH:16]=2)[CH2:11][CH2:10]1)(C)(C)C.C([SiH](CC)CC)C.C(O)(C(F)(F)F)=O>C(Cl)Cl>[CH3:35][C:25]1[CH:24]=[C:23]([CH:28]=[CH:27][C:26]=1[CH:29]1[CH2:34][CH2:33][S:32][CH2:31][CH2:30]1)[O:22][CH2:21][C:18]1[CH:19]=[CH:20][C:15]([CH:12]2[CH2:11][CH2:10][N:9]([CH2:8][CH2:7][C:6]([OH:36])=[O:5])[CH2:14][CH2:13]2)=[CH:16][CH:17]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of crude 3-(4-{4-[3-Methyl-4-(tetrahydro-thiopyran-4-yl)-phenoxymethyl]-phenyl}-piperidin-1-yl)-propionic acid tert-butyl ester in dry DCM (7 mL) is added triethyl silane (5 eq., 4.442 mmol, 517 mg, 0.71 mL) followed by TFA (7 mL). The resulting mixture is stirred at room temperature for 1 hour. After concentration, the crude product is purified by preparative RP LC-MS to give 3-(4-{4-[3-methyl-4-(tetrahydro-thiopyran-4-yl)-phenoxymethyl]-phenyl}-piperidin-1-yl)-propionic acid as a tan solid. 1H NMR (DMSO-d6, 400 MHz) δ 7.44-7.38 (m, 2H), 7.30-7.21 (m, 2H), 7.13-7.05 (m, 1H), 6.83-6.72 (m, 2H), 5.02 (s, 2H), 3.61-3.52 (m, 2H), 3.15-3.05 (m, 2H), 2.89-2.75 (m, 5H), 2.72-2.60 (m, 3H), 2.33-2.20 (m, 3H), 2.06-1.88 (m, 6H), 1.77-1.61 (m, 1H); MS (ES+): (454.2, M+1)+.
Workup
- concentrationAfter concentration
- customthe crude product is purified by preparative RP LC-MS
Sources & evidence
- ORD record
- ord-7a260d1bcfd34f3ea492949af7fa9a0c
- Source dataset
- uspto-grants-2009_08
- Patent number
- US07572811B2
Reaction notes
Loading…